Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Apr 23:340:c1777.
doi: 10.1136/bmj.c1777.

Nurse led, home based self help treatment for patients in primary care with chronic fatigue syndrome: randomised controlled trial

Collaborators, Affiliations
Randomized Controlled Trial

Nurse led, home based self help treatment for patients in primary care with chronic fatigue syndrome: randomised controlled trial

Alison J Wearden et al. BMJ. .

Abstract

Objective: To evaluate the effectiveness of home delivered pragmatic rehabilitation-a programme of gradually increasing activity designed collaboratively by the patient and the therapist-and supportive listening-an approach based on non-directive counselling-for patients in primary care with chronic fatigue syndrome/myalgic encephalomyelitis or encephalitis (CFS/ME).

Design: Single blind, randomised, controlled trial.

Setting: 186 general practices across the north west of England between February 2005 and May 2007.

Participants: 296 patients aged 18 or over with CFS/ME (median illness duration seven years) diagnosed using the Oxford criteria.

Interventions: Participants were randomly allocated to pragmatic rehabilitation, supportive listening, or general practitioner treatment as usual. Both therapies were delivered at home in 10 sessions over 18 weeks by one of three adult specialty general nurses who had received four months' training, including supervised practice, in each of the interventions. GP treatment as usual was unconstrained except that patients were not to be referred for systematic psychological therapies during the treatment period. Main outcome measures The primary clinical outcomes were fatigue and physical functioning at the end of treatment (20 weeks) and 70 weeks from recruitment compared with GP treatment as usual. Lower fatigue scores and higher physical functioning scores denote better outcomes.

Results: A total of 257 (87%) of the 296 patients who entered the trial were assessed at 70 weeks, the primary outcome point. Analysis was on an intention to treat basis, with robust treatment effects estimated after adjustment for missing data using probability weights. Immediately after treatment (at 20 weeks), patients allocated to pragmatic rehabilitation (n=95) had significantly improved fatigue (effect estimate -1.18, 95% confidence interval -2.18 to -0.18; P=0.021) but not physical functioning (-0.18, 95% CI -5.88 to +5.52; P=0.950) compared with patients allocated to treatment as usual (n=100). At one year after finishing treatment (70 weeks), there were no statistically significant differences in fatigue or physical functioning between patients allocated to pragmatic rehabilitation and those on treatment as usual (-1.00, 95% CI -2.10 to +0.11; P=0.076 and +2.57, 95% CI 3.90 to +9.03; P=0.435). At 20 weeks, patients allocated to supportive listening (n=101) had poorer physical functioning than those allocated to treatment as usual (-7.54, 95% CI -12.76 to -2.33; P=0.005) and no difference in fatigue. At 70 weeks, patients allocated to supportive listening did not differ significantly from those allocated to treatment as usual on either primary outcome.

Conclusions: For patients with CFS/ME in primary care, pragmatic rehabilitation delivered by trained nurse therapists improves fatigue in the short term compared with unconstrained GP treatment as usual, but the effect is small and not statistically significant at one year follow-up. Supportive listening delivered by trained nurse therapists is not an effective treatment for CFS/ME. Trial registration International Standard Randomised Controlled Trial Number IRCTN74156610.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: (1) No financial support for the submitted work from anyone other than their employer; (2) No financial relationships with commercial entities that might have an interest in the submitted work; (3) No spouses, partners, or children with relationships with commercial entities that might have an interest in the submitted work; (4) No non-financial interests that may be relevant to the submitted work.

Figures

None
Fig 1 CONSORT diagram showing patient flow through the trial. *One patient randomised to pragmatic rehabilitation was treated by a therapist other than the one to whom she was randomised. †One patient originally randomised to supportive listening was treated with pragmatic rehabilitation, and by a different therapist from the one originally randomised, because another person living at the same address was receiving pragmatic rehabilitation in the trial. ‡One patient randomised to supportive listening was admitted to the trial with an SF-36 score of 75% and completed the trial. §One patient randomised to supportive listening subsequently received a diagnosis of multiple sclerosis and withdrew from treatment. CFS/ME, chronic fatigue syndrome/myalgic encephalomyelitis or encephalitis
None
Fig 2 Mean scores on the Chalder et al fatigue scale, SF-36 physical functioning scale, Jenkins et al sleep scale, and the hospital anxiety and depression scales (HADS) depression subscale at baseline (week 0), after treatment (week 20), and at one year follow-up (week 70) for patients allocated to the three treatment arms. *Significant difference between PR and GPTAU; †significant difference between SL and GPTAU, P<0.05 for both. GPTAU, general practitioner treatment as usual; PR, pragmatic rehabilitation; SL, supportive listening

Comment in

Similar articles

Cited by

References

    1. Sharpe MC, Archard LC, Banatvala JE, Borysiewicz LK, Clare AW, David A, et al. A report—chronic fatigue syndrome: guidelines for research. J R Soc Med 1991;84:118-21. - PMC - PubMed
    1. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A, et al. The chronic fatigue syndrome—a comprehensive approach to its definition and study. Ann Intern Med 1994;121:953-9. - PubMed
    1. Komaroff AL, Fagioli LR, Doolittle TH, Gandek B, Gleit MA, Guerriero RT, et al. Health status in patients with chronic fatigue syndrome and in general population and disease comparison groups. Am J Med 1996;101:281-90. - PubMed
    1. Bombardier CH, Buchwald D. Chronic fatigue, chronic fatigue syndrome, and fibromyalgia—disability and health-care use. Med Care 1996;34:924-30. - PubMed
    1. McCrone P, Darbishire L, Ridsdale L, Seed P. The economic cost of chronic fatigue and chronic fatigue syndrome in UK primary care. Psychol Med 2003;33:253-61. - PubMed

Publication types

MeSH terms

Associated data

  NODES
COMMUNITY 2
INTERN 2
Note 1
twitter 2